Wolcott-Rallison Syndrome- Endocrinopathy with Recurrent Acute Liver Failure

Joseph J Valamparampil1, Naresh Shanmugam2, Mohamed Rela3

  • 1Department of Paediatric Hepatology, Institute of Liver Disease and Transplantation, Dr Rela Institute and Medical Centre, Chennai, India. josephvalam@yahoo.co.in.

Indian Pediatrics
|December 30, 2019
PubMed

Insights

Wolcott-Rallison Syndrome, a rare genetic condition, can cause recurrent acute liver failure in children. Evaluating for autoimmune, metabolic, or genetic disorders is crucial for managing this risk.

Area of Science:

  • Pediatric Endocrinology
  • Hepatology
  • Medical Genetics

Background:

  • Wolcott-Rallison Syndrome (WRS) is a rare genetic disorder characterized by early-onset diabetes and hypothyroidism.
  • Recurrent acute liver failure (ALF) is a serious complication that can occur in children with WRS.
  • Early diagnosis and management are critical for improving outcomes in children with WRS.

Observation:

  • A 2-year-old child diagnosed with Wolcott-Rallison Syndrome experienced two episodes of acute liver failure.
  • The child recovered from both episodes but remains at high risk for future liver events.
  • This case highlights the unpredictable nature of liver involvement in WRS.

Findings:

  • Children with recurrent acute liver failure require thorough evaluation for underlying causes.
  • Autoimmune, metabolic, and genetic disorders are important differential diagnoses for pediatric ALF.
  • Genetic testing should be considered in the diagnostic workup of children with unexplained recurrent acute liver failure.

Implications:

  • Identifying the underlying genetic basis of liver failure in WRS is essential for risk stratification.
  • Prompt diagnosis and management of associated metabolic and autoimmune conditions can mitigate ALF risk.
  • This case underscores the importance of a multidisciplinary approach in managing complex pediatric genetic syndromes.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
430
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
140
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.4K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
660
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
174